Product Overview
PT-141 10mg (Bremelanotide) is a synthetic short-chain research peptide composed of a defined amino‑acid sequence with targeted structural modifications intended to support molecular stability and analytical consistency. Produced using solid‑phase peptide synthesis, it is supplied as a white to off‑white lyophilized powder that reflects the expected physicochemical profile of high-purity peptides. PT‑141 10mg is commonly utilized in in-vitro research applications where controlled sequence integrity, reproducible molecular characteristics, and reliable analytical verification are important.
Handling & Storage
PT‑141 10mg is carefully handled and packaged to ensure stability during storage and ease of use in laboratory settings. Proper storage conditions, including low temperature and protection from moisture, help maintain the integrity of the lyophilized powder over time. Each vial is labeled with concentration and batch information to support accurate tracking in research workflows.
Related Products
Researchers may also consider Melanotan II 10mg, BPC-157 5mg, or TB-500 5mg for related research studies.
Disclaimer: “PT-141” is the nonproprietary designation for this compound and is not a proprietary or trademarked term. This description is provided solely for research and informational purposes and is not intended to imply therapeutic approval or clinical use. PT-141 is strictly for in vitro laboratory research and is not approved for human or animal use.


